DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ortho TRI-Cyclen (Norgestimate / Ethinyl Estradiol) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ortho TRI-Cyclen side effects in 21 year old female

Reported by a consumer/non-health professional from United States on 2012-06-11

Patient: 21 year old female, weighing 68.0 kg (149.7 pounds)

Reactions: Brain Death, Pulmonary Thrombosis, Myocardial Infarction, Loss of Consciousness, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ortho TRI-Cyclen



Possible Ortho TRI-Cyclen side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-05

Patient: female, weighing 63.5 kg (139.7 pounds)

Reactions: Pulmonary Embolism, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ortho TRI-Cyclen
    Dosage: daily po
    Administration route: Oral
    Indication: Contraception

Reclipsen
    Dosage: daily po
    Administration route: Oral
    Indication: Contraception

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017